Cochrane Clinical Answers - Access Denied - How does early initiation compare with late initiation of disease-modifying drugs after a first clinical attack suggestive of multiple sclerosis?

Question:How does early initiation compare with late initiation of disease-modifying drugs after a first clinical attack suggestive of multiple sclerosis?

THIS CLINICAL ANSWER IS NEW Published Online: 30 AUG 2017

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer compares early and late initiation of disease-modifying drugs after a first clinical attack suggestive of multiple sclerosis.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.